Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1

New York University585 enrolled

Overview

The purpose of this study is to look at how feasible it is to incorporate a state-of-the-art smoking cessation treatment program into community substance abuse treatment programs and its impact on substance abuse and cigarette smoking.

Study Type

INTERVENTIONAL

Purpose

TREATMENT

Enrollment

585

Conditions

Tobacco Use Disorder

Interventions

nicotine transdermal systemDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient is alcohol or drug dependent, in Outpatient Drug-Free or Opiate Substitute program and is interested in quitting smoking Exclusion Criteria: * Patient is psychotic * Use of smokeless tobacco * Use of other smoking cessasation product * Pregnancy * Patient has hyper-tension, heart problems, or skin condition

Locations (13)

Matrix Institute on Addictions

Los Angeles, California, United States

Tarzana Treatment Center

Tarzana, California, United States

SPECTRUM

Miami, Florida, United States

Outcomes

Primary Outcomes

Drug use

Smoking Cessation

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.